Clinical Oncology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adrenocortical Cancer
Studies by A. Lachenmayer and co-authors describe new findings in adrenocortical cancer
August 3rd, 2009
According to recent research published in the journal Hormone and Metabolic Research, "Expression of the intermediate filament, nestin, was long believed to be restricted to neuroectodermal stem cells. However, nestin expression has recently been detected in several tumors." "Since adrenocortical carcinoma, a tumor entity still very difficult to classify, may gain the ability to aberrantly express neuroectodermal proteins including chromogranin A and synaptophysin, we asked the question whether nestin might also be detected in adrenocortical carcinomas, and if so, whether it might serve as a tool for clinical pathology. Therefore, we Studied the expression of...
Source: Clinical Oncology Week (2009-08-03)
|
